An open-label study of nelotanserin in patients with Lewy body dementia who have frequent visual hallucinations or REM sleep behaviors
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to evaluate the long-term safety of the study drug nelotanserin and to assess the effects of nelotanserin in subjects experiencing frequent visual hallucination and/or REM sleep behavior disorders due to dementia with Lewy bodies.
Description
The purpose of this study is to evaluate the long-term safety of the study drug nelotanserin and to assess the effects of nelotanserin in subjects experiencing frequent visual hallucination and/or REM sleep behavior disorders due to dementia with Lewy bodies.
Details
| Condition | dementia with Lewy bodies |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX7577 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.